PyroGenesis Canada (PYRGF) Competitors $0.16 -0.01 (-7.97%) As of 03:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock PYRGF vs. THTX, GLSI, MOLN, AVTX, PLX, BHST, FBRX, GNLX, ELDN, and TILShould you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include Theratechnologies (THTX), Greenwich LifeSciences (GLSI), Molecular Partners (MOLN), Avalo Therapeutics (AVTX), Protalix BioTherapeutics (PLX), BioHarvest Sciences (BHST), Forte Biosciences (FBRX), Genelux (GNLX), Eledon Pharmaceuticals (ELDN), and Instil Bio (TIL). These companies are all part of the "pharmaceutical products" industry. PyroGenesis Canada vs. Its Competitors Theratechnologies Greenwich LifeSciences Molecular Partners Avalo Therapeutics Protalix BioTherapeutics BioHarvest Sciences Forte Biosciences Genelux Eledon Pharmaceuticals Instil Bio PyroGenesis Canada (NASDAQ:PYRGF) and Theratechnologies (NASDAQ:THTX) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Which has preferable earnings and valuation, PYRGF or THTX? Theratechnologies has higher revenue and earnings than PyroGenesis Canada. Theratechnologies is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M3.36-$21.12M-$0.03-5.47Theratechnologies$84.38M1.85-$8.31M-$0.19-17.84 Do analysts recommend PYRGF or THTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Theratechnologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is PYRGF or THTX more profitable? Theratechnologies has a net margin of -10.85% compared to PyroGenesis Canada's net margin of -115.14%. Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% N/A -60.81% Theratechnologies -10.85%N/A -9.83% Which has more risk & volatility, PYRGF or THTX? PyroGenesis Canada has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Do institutionals & insiders hold more shares of PYRGF or THTX? 0.0% of PyroGenesis Canada shares are owned by institutional investors. 47.7% of PyroGenesis Canada shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor PYRGF or THTX? In the previous week, Theratechnologies had 2 more articles in the media than PyroGenesis Canada. MarketBeat recorded 2 mentions for Theratechnologies and 0 mentions for PyroGenesis Canada. Theratechnologies' average media sentiment score of 1.91 beat PyroGenesis Canada's score of 0.00 indicating that Theratechnologies is being referred to more favorably in the news media. Company Overall Sentiment PyroGenesis Canada Neutral Theratechnologies Very Positive SummaryTheratechnologies beats PyroGenesis Canada on 8 of the 14 factors compared between the two stocks. Get PyroGenesis Canada News Delivered to You Automatically Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PYRGF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYRGF vs. The Competition Export to ExcelMetricPyroGenesis CanadaPharmaceutical IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$30.76M$862.10M$7.78B$10.30BDividend YieldN/A4.84%4.58%4.62%P/E Ratio-2.731.20303.2426.11Price / Sales3.3626.06277.94171.57Price / CashN/A17.6528.2661.52Price / Book-16.406.464.726.30Net Income-$21.12M-$5.42M$799.16M$271.03M7 Day Performance-18.00%-0.69%0.06%-0.14%1 Month Performance-23.83%5.09%2.15%6.42%1 Year Performance-73.95%29.49%26.66%28.81% PyroGenesis Canada Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYRGFPyroGenesis CanadaN/A$0.16-8.0%N/A-72.3%$30.76M$9.14M-2.7390High Trading VolumeTHTXTheratechnologiesN/A$3.32+0.5%N/A+189.7%$152.42M$85.87M-17.45140Positive NewsGLSIGreenwich LifeSciences1.5965 of 5 stars$11.14-1.1%$42.00+276.9%-28.4%$151.88MN/A-8.193MOLNMolecular Partners2.2888 of 5 stars$3.72-0.5%$8.00+115.0%-26.7%$150.25M$5.65M-1.79180AVTXAvalo Therapeutics3.9492 of 5 stars$11.32+16.0%$31.67+179.7%+19.0%$148.86M$440K0.0040High Trading VolumePLXProtalix BioTherapeutics2.5875 of 5 stars$1.86-4.9%$15.00+708.6%+90.7%$147.90M$61.95M-14.27200News CoveragePositive NewsBHSTBioHarvest Sciences2.2124 of 5 stars$9.00+3.2%$13.67+51.9%N/A$147.78M$25.19M-12.86N/AGap DownFBRXForte Biosciences3.1901 of 5 stars$11.88-3.7%$68.00+472.6%+114.3%$147.61MN/A-0.735Positive NewsGNLXGenelux1.5382 of 5 stars$3.90-4.6%$20.33+421.4%+100.5%$147.30M$10K-4.5310Positive NewsELDNEledon Pharmaceuticals2.9373 of 5 stars$2.44+2.8%$10.00+310.5%-4.0%$145.87MN/A-2.0810News CoveragePositive NewsTILInstil Bio3.2845 of 5 stars$21.61-6.3%$88.50+309.6%-74.3%$145.83MN/A-1.67410Positive NewsGap Down Related Companies and Tools Related Companies THTX Alternatives GLSI Alternatives MOLN Alternatives AVTX Alternatives PLX Alternatives BHST Alternatives FBRX Alternatives GNLX Alternatives ELDN Alternatives TIL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYRGF) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PyroGenesis Canada Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PyroGenesis Canada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.